Legend:
Figure 1. HV Skin Lesions in Sun-exposed Areas. Consent to publish
photographs of the patient for the case report was obtained from the
patient’s parent.
Figure 2. Bone marrow with lymphocytic infiltrate and scattered
EBV-positive lymphocytes
Figure 3. Whole Blood and CSF EBV Levels by Day of Management with
Interventions. Day 0 represents the initiation of systemic interventions
with oral valganciclovir. Abbreviations: GCV, ganciclovir; DEX,
dexamethasone; IT/IO HC/MTX, intrathecal/Intra-Ommaya hydrocortisone and
methotrexate; BTZ, bortezomib; BSF, busulfan; PBSCs, peripheral blood
stem cells; PTCy, post-transplantation cyclophosphamide.
Figure 4. Angiography at 6 Months Prior to HSCT shows severely dilated
RCA with low flow in the RCA, left anterior descending artery with
multiple aneurysms with a beaded appearance, and circumflex artery with
multiple large aneurysms.
Figure 5. CTA performed day +213 after HSCT demonstrates Middle Cerebral
Artery Aneurysm
Figure 6. Flow-diverting Stent with Aneurysm Coiling
Figure 7. Head CT day +235 after HSCT demonstrates massive diffuse
subarachnoid hemorrhage with right frontal lobe hemorrhage and
hemorrhage into the ventricular system.
Figure 1.